Ependymomas in Adults

被引:111
作者
Gilbert, Mark R. [1 ]
Ruda, Roberta [2 ,3 ,4 ]
Soffietti, Riccardo [2 ,3 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77025 USA
[2] Univ Turin, Dept Neurosci, Div Neurooncol, Turin, Italy
[3] Univ Turin, Dept Oncol, Turin, Italy
[4] San Giovanni Battista Hosp, Turin, Italy
关键词
Ependymoma; Adult; Pediatric; Therapy; RECURRENT INTRACRANIAL EPENDYMOMA; PRIMITIVE NEUROECTODERMAL TUMORS; PROGNOSTIC-FACTORS; SUPRATENTORIAL EPENDYMOMAS; ANAPLASTIC EPENDYMOMAS; CHROMOSOMAL IMBALANCES; RETROSPECTIVE SERIES; OUTCOME ANALYSIS; IDENTIFICATION; CHEMOTHERAPY;
D O I
10.1007/s11910-010-0109-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ependymomas are rare primary central nervous system tumors in adults. They occur most commonly in the spinal cord, where histopathologic evaluation is critical to differentiate the grade I myxopapillary ependymoma from the grade II ependymoma or grade III anaplastic ependymoma. Brain ependymomas are either grade II or III. Treatment for all grades and types includes maximum surgical resection. For myxopapillary ependymoma, complete removal while maintaining capsule integrity may be curative. Some grade II ependymomas may be observed carefully after imaging confirms complete resection, but grade III tumors require adjuvant radiation treatment. Radiation commonly is given to the region of tumor, except in cases in which there is imaging or cerebrospinal fluid evidence of tumor dissemination. Chemotherapy has not been studied extensively, although most reports suggest only modest benefit. Ongoing laboratory studies have uncovered important signal transduction pathways that may be better therapeutic targets, leading to the development of clinical trials using targeted agents.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 62 条
[1]  
ARMSTRONG TS, 2010, NEUROONCOL IN PRESS
[2]   A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia [J].
Brandes, AA ;
Cavallo, G ;
Reni, M ;
Tosoni, A ;
Nicolardi, L ;
Scopece, L ;
Franceschi, E ;
Sotti, G ;
Talacchi, A ;
Turazzi, S ;
Ermani, M .
CANCER, 2005, 104 (01) :143-148
[3]   O6-Methylguanine-DNA-Methyltransferase in recurring anaplastic ependymomas: PCR and immunohistochemistry [J].
Buccoliero, A. M. ;
Castiglione, F. ;
Degl'innocenti, D. Rossi ;
Paglierani, M. ;
Maio, V. ;
Gheri, C. F. ;
Garbini, F. ;
Moncini, D. ;
Taddei, A. ;
Sardi, I. ;
Sanzo, M. ;
Giordano, F. ;
Mussa, F. ;
Genitori, L. ;
Taddei, G. L. .
JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) :263-268
[4]  
Central Brain Tumor Registry of the United States, 2005, STAT REP PRIM BRAIN
[5]   Temozolomide for Recurrent Intracranial Supratentorial Platinum-Refractory Ependymoma [J].
Chamberlain, Marc C. ;
Johnston, Sandra K. .
CANCER, 2009, 115 (20) :4775-4782
[6]   Recurrent intracranial ependymoma in children: Salvage therapy with oral etoposide [J].
Chamberlain, MC .
PEDIATRIC NEUROLOGY, 2001, 24 (02) :117-121
[7]   Imaging predictors of intracranial ependymomas [J].
Chen, CJ ;
Tseng, YC ;
Hsu, HL ;
Jung, SM .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2004, 28 (03) :407-413
[8]   Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis [J].
de Bont, Judith M. ;
den Boer, Monique L. ;
Kros, Johan M. ;
Passier, Monique M. C. J. ;
Reddinglus, Roel E. ;
Smitt, Peter A. E. Sillevis ;
Luider, Theo M. ;
Pieters, Rob .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2007, 66 (06) :505-516
[9]   A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas [J].
De Bustos, C ;
Smits, A ;
Strömberg, B ;
Collins, VP ;
Nistér, M ;
Afink, G .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (01) :31-37
[10]   Recurrent spinal ependymoma showing partial remission under Imatimib [J].
Fakhrai, N ;
Neophytou, P ;
Dieckmann, K ;
Nemeth, A ;
Prayer, D ;
Hainfellner, J ;
Marosi, C .
ACTA NEUROCHIRURGICA, 2004, 146 (11) :1255-1258